InstalabComprehensive ANA Panel
Should you take a Comprehensive ANA Panel test?
This test is most useful if any of these apply to you.
12 Biomarkers Included
- ANA ScreenAn antibody your immune system mistakenly produces against the contents of your own cells, signaling that your body may be attacking its own tissues.
- ANA TiterAn antibody your immune system makes against your own cell components, measured by how far a blood sample can be diluted and still show a reaction, reflecting whether your body is mistakenly attacking its own tissues.
- ANA PatternA classification of the visual staining shape your immune system's self-targeting antibodies create on laboratory cells, revealing which parts of your own cells are under attack and pointing toward specific autoimmune diseases.
- DNA (DS) AntibodyAn autoantibody produced by immune cells that mistakenly targets your own DNA, serving as one of the most specific blood markers for lupus and a tracker of lupus kidney disease activity.
- Anti-Sm AntibodyAn autoantibody targeting a protein complex inside the cell nucleus that, when present in the blood, serves as one of the strongest confirmatory signals for lupus.
- Scleroderma AntibodyAn autoantibody that targets a specific nuclear enzyme and, when present, strongly signals systemic sclerosis (scleroderma), a condition that causes skin thickening and internal organ damage.
- J-o1 AntibodyAn autoantibody that your immune system mistakenly produces against one of your own protein-building enzymes, signaling that the body may be attacking its own muscles, lungs, or joints.
- SS-A AntibodyAn autoantibody your immune system makes against its own proteins, used to detect Sjogren's syndrome, lupus, and other conditions where the body mistakenly attacks its own tissues.
- SS-B AntibodyAn autoantibody your immune system makes against one of its own proteins, signaling that your body may be attacking its own tissues in conditions like Sjogren's syndrome or lupus.
- RNP AntibodyAn autoantibody produced by immune cells that mistakenly targets a normal protein complex inside cell nuclei, signaling that the immune system may be attacking the body's own tissues.
- Chromatin AntibodyAn autoantibody your immune system makes against its own DNA packaging material, signaling that the body may be attacking its own tissues in conditions like lupus.
- Centromere B AntibodyAn autoantibody your immune system makes against a structural protein in your chromosomes, serving as a specific signal of autoimmune connective tissue disease, especially a form of scleroderma that affects the skin and blood vessels of the hands and face.
About Comprehensive ANA Panel
Joint pain, fatigue, dry eyes, hair thinning, a rash that flares in the sun. These symptoms can have dozens of explanations, but when they cluster, autoimmunity moves up the list. A standard antinuclear antibody screen tells you whether your immune system is producing antibodies against your own cells, but it stops there. It cannot tell you which autoimmune disease, if any, is driving the picture.
This panel goes the full distance. It runs the screening test, measures how strong the antibody signal is, identifies the staining pattern, and then tests for nine specific antibodies that each point toward a different autoimmune condition. The result is a fingerprint, not a flag.
What This Panel Reveals
Your immune system normally ignores your own tissues. In systemic autoimmune disease, that tolerance breaks down and antibodies begin attacking proteins inside your own cells, especially proteins in the cell nucleus. Different diseases produce different patterns of antibodies, which is why a careful panel can sort one condition from another.
The panel covers three layers. The first layer is screening: is there any antinuclear antibody activity at all, how intense is it, and what does it look like under a microscope. The second layer is lupus-focused: antibodies against double-stranded DNA, Smith protein, chromatin, and ribonucleoprotein, which together carry strong weight for systemic lupus erythematosus and overlap conditions. The third layer covers neighboring autoimmune diseases: SS-A and SS-B for Sjögren's syndrome, Scl-70 and centromere B for the two major forms of scleroderma, and Jo-1 for inflammatory muscle disease and antisynthetase syndrome.
No single test in this panel diagnoses a disease on its own. Used together, they answer a more useful question: which autoimmune disease, if any, fits your antibody profile and your symptoms.
How to Read Your Results Together
The screen result drives everything else. If the screen is negative and you have no autoimmune symptoms, the specific antibodies almost never matter. If the screen is positive, the titer (how diluted your blood can be before the signal disappears) tells you how strong the antibody activity is. The pattern then narrows the search. The 2019 American College of Rheumatology and European League Against Rheumatism classification criteria for lupus use a screen titer of 1:80 or higher as the required entry point.
Here is how the antibody combinations typically map to conditions.
| Pattern of Results | What It Often Suggests |
|---|---|
| Positive screen, anti-dsDNA positive, anti-Sm positive or chromatin positive | Systemic lupus erythematosus, often with kidney involvement when dsDNA is high |
| Positive screen, SS-A positive, SS-B positive | Sjögren's syndrome, sometimes with lupus overlap |
| Positive screen, centromere B positive | Limited cutaneous scleroderma, often the CREST form |
| Positive screen, Scl-70 positive | Diffuse cutaneous systemic sclerosis, with higher risk of lung fibrosis |
| Positive screen, high RNP, others negative | Mixed connective tissue disease |
| Positive screen, Jo-1 positive | Antisynthetase syndrome with muscle inflammation and lung involvement |
Anti-dsDNA is the most useful antibody for tracking lupus disease activity over time, with sensitivity around 70 percent and specificity above 95 percent for the condition. Anti-Sm is less sensitive at roughly 30 percent but is so specific for lupus that a positive result almost always confirms it. SS-A appears in 70 to 100 percent of Sjögren's cases and in 30 to 40 percent of lupus cases, which is why it never reads alone.
When Results Can Be Misleading
A positive screen does not mean disease. Roughly 13 percent of healthy adults have a positive ANA at the 1:80 dilution and about 5 percent stay positive at 1:160 in population studies, with the rate rising with age and being more common in women. A low-titer positive in someone without symptoms is usually background noise.
Certain medications can drive a positive result, including hydralazine, procainamide, isoniazid, minocycline, and some tumor necrosis factor blockers. Recent viral infections, pregnancy, and chronic inflammation from any cause can also nudge antibody levels up temporarily. The specific antibodies in this panel are much less likely to be falsely positive than the screen itself, which is one of the reasons the panel is more useful than the screen alone.
Tracking Over Time
Specific antibodies generally stay positive for life once they appear, so repeating them is not the goal. What changes is the titer, especially for anti-dsDNA. Rising anti-dsDNA levels often precede a lupus flare by weeks to months and are used to time treatment changes. A single result captures a moment. Serial measurement reveals the trajectory.
If your panel is fully negative and you remain asymptomatic, retesting yearly is reasonable, especially if you have a family history of autoimmune disease. If you are positive but have no diagnosis, retest every six to twelve months alongside a symptom review. If you carry a diagnosis, your rheumatologist will set the cadence, but anti-dsDNA in active lupus is often checked every three months.
What to Do with Your Results
A fully negative panel in someone with mild or non-specific symptoms is reassuring and points the workup elsewhere, toward thyroid disease, fibromyalgia, sleep, or non-autoimmune inflammation. A positive screen at low titer without specific antibodies usually warrants symptom tracking rather than treatment.
A positive screen with one or more specific antibodies is a reason to see a rheumatologist. Bring the full panel result with you. Useful companion tests include complete blood count, kidney function, urinalysis with a protein-to-creatinine ratio, complement levels (C3 and C4), and erythrocyte sedimentation rate with C-reactive protein. These show whether the autoimmune process is currently active in the kidneys, blood, or vessels.
Anti-dsDNA positivity warrants particular attention to the kidneys, since this antibody is strongly linked to lupus nephritis. SS-A positivity in someone planning pregnancy carries specific implications for the baby's heart, since these antibodies can cross the placenta and cause congenital heart block in a small percentage of pregnancies. Centromere B and Scl-70 results should prompt screening for the lung and esophageal involvement that systemic sclerosis can cause.